Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
I-Mab Strengthens Senior Executive Team with New Chief Financial Officer and Chief Strategy Officer Appointments 2021-11-01 20:00
Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety Disorder PREVAIL Study 2021-11-01 18:00
HOPSTEM completed 40 million USD series B financing, to develop safe, effective and affordable iPSC cell therapies for global patients 2021-11-01 08:00
Invetech Named Victorian Top Exporter of the Year 2021-10-30 05:35
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia 2021-10-29 19:15
China's New Regulation on Internet Healthcare will Benefit Platforms like WeDoctor 2021-10-29 17:41
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81% 2021-10-29 17:17
IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by FDA 2021-10-29 14:12
Exosystems Raises $3.9M Series A Funding, on Mission to Provide AI-based Digital Care for Musculoskeletal System 2021-10-29 07:47
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology. 2021-10-28 21:00
Osfirm to Launch Novel Implantable Biomaterial Whitlockite with Excellent Biodegradability and Bone Regenerative and Reconstructive Properties into Global Market by the Year 2023 2021-10-28 21:00
HanAll Biopharma Reports Third Quarter 2021 Results 2021-10-28 21:00
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility 2021-10-28 08:30
Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease (cGvHD) in Adults 2021-10-28 05:48
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients 2021-10-27 20:47
Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production 2021-10-26 20:00
I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China 2021-10-26 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 2021-10-26 07:30
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage 2021-10-25 20:30
1 156 157 158 159 160 433